Healthcare -
Biotechnology - NASDAQ - US
$ 46.86
-4.01 %
$ 2.02 B
Market Cap
-10.7
P/E
SLNO - COST OF REVENUE
Cost of Revenue SLNO - Soleno Therapeutics, Inc.
1.96 M
LAST VALUE
-5.81%
2 YEAR CAGR
0.40%
5 YEAR CAGR
0.00%
10 YEAR CAGR